Skip to content

Clinical trials

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Country / region: Japan Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20053
20061
20075
20081
20092
20114
20123
20133
20141
20172
20212
20222
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Recruiting6
Unknown status2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals15
Pfizer4
Bristol-Myers Squibb3
Kanto CML Study Group3
Ariad Pharmaceuticals1
Ascentage Pharma Group Inc.1
Enliven Therapeutics1
Keio University1
Otsuka Pharmaceutical Co., Ltd.1
Poitiers University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive32
Leukemia5
Bone Marrow Diseases4
Leukemia, Myeloid, Chronic-Phase4
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Hematologic Neoplasms3
Leukemia, Myeloid3
Myeloproliferative Disorders3
Bronchiolitis Obliterans Syndrome2
Hematologic Diseases2

Trials

Showing 51 to 32 of 32. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.